$19.29
0.94% yesterday
Nasdaq, Jun 26, 10:00 pm CET
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

CareDx, Inc. Target price 2025 - Analyst rating & recommendation

CareDx, Inc. Classifications & Recommendation:

Buy
67%
Hold
33%

CareDx, Inc. Price Target

Target Price $25.50
Price $19.29
Potential
Number of Estimates 9
9 Analysts have issued a price target CareDx, Inc. 2026 . The average CareDx, Inc. target price is $25.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 10 Analysts recommend CareDx, Inc. to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CareDx, Inc. stock has an average upside potential 2026 of . Most analysts recommend the CareDx, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 333.79 378.21
19.07% 13.31%
EBITDA Margin -15.35% 8.64%
57.65% 156.29%
Net Margin 15.74% 8.97%
123.19% 43.02%

10 Analysts have issued a sales forecast CareDx, Inc. 2025 . The average CareDx, Inc. sales estimate is

$378m
Unlock
. This is
9.18% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$393m 13.32%
Unlock
, the lowest is
$362m 4.54%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $334m 19.07%
2025
$378m 13.31%
Unlock
2026
$437m 15.46%
Unlock
2027
$494m 13.03%
Unlock

10 Analysts have issued an CareDx, Inc. EBITDA forecast 2025. The average CareDx, Inc. EBITDA estimate is

$32.7m
Unlock
. This is
181.86% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$35.1m 187.82%
Unlock
, the lowest is
$29.5m 173.91%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-51.2m 49.57%
2025
$32.7m 163.78%
Unlock
2026
$60.1m 84.08%
Unlock
2027
$88.1m 46.47%
Unlock

EBITDA Margin

2024 -15.35% 57.65%
2025
8.64% 156.29%
Unlock
2026
13.77% 59.38%
Unlock
2027
17.85% 29.63%
Unlock

10 CareDx, Inc. Analysts have issued a net profit forecast 2025. The average CareDx, Inc. net profit estimate is

$33.9m
Unlock
. This is
42.35% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$37.3m 36.68%
Unlock
, the lowest is
$30.4m 48.39%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $52.6m 127.62%
2025
$33.9m 35.43%
Unlock
2026
$60.5m 78.22%
Unlock
2027
$81.7m 35.12%
Unlock

Net Margin

2024 15.74% 123.19%
2025
8.97% 43.02%
Unlock
2026
13.85% 54.40%
Unlock
2027
16.55% 19.49%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.93 0.61
126.27% 34.41%
P/E 31.53
EV/Sales 2.23

10 Analysts have issued a CareDx, Inc. forecast for earnings per share. The average CareDx, Inc. EPS is

$0.61
Unlock
. This is
42.45% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.67 36.79%
Unlock
, the lowest is
$0.55 48.11%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.93 126.27%
2025
$0.61 34.41%
Unlock
2026
$1.09 78.69%
Unlock
2027
$1.47 34.86%
Unlock

P/E ratio

Current 18.20 558.18%
2025
31.53 73.26%
Unlock
2026
17.69 43.89%
Unlock
2027
13.09 26.00%
Unlock

Based on analysts' sales estimates for 2025, the CareDx, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.43 29.26%
2025
2.23 8.26%
Unlock
2026
1.93 13.39%
Unlock
2027
1.71 11.53%
Unlock

P/S ratio

Current 3.10 16.48%
2025
2.84 8.41%
Unlock
2026
2.46 13.39%
Unlock
2027
2.18 11.53%
Unlock

Current CareDx, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked May 05 2025
Stephens & Co.
Locked
Locked
Locked May 05 2025
Goldman Sachs
Locked
Locked
Locked Apr 17 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 03 2025
Stephens & Co.
Locked
Locked
Locked Feb 27 2025
Wells Fargo
Locked
Locked
Locked Jan 15 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 14 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
May 05 2025
Locked
Stephens & Co.:
Locked
Locked
May 05 2025
Locked
Goldman Sachs:
Locked
Locked
Apr 17 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 03 2025
Locked
Stephens & Co.:
Locked
Locked
Feb 27 2025
Locked
Wells Fargo:
Locked
Locked
Jan 15 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 14 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today